CVE-2024-41668
cBioPortal Proxy Endpoint Vulnerabliity
- Published
- Last modified
- Where the record stands: published, rejected by its publisher, or superseded by another id.What do these mean? →
- published
- Whether CISA lists it in its Known Exploited Vulnerabilities catalog: proof that attackers are using it.What do these mean? →
- Not listed in CISA KEV
- Fix
- Fixed in 6.0.12
- Whether working attack code is public (Exploit-DB, Metasploit, Nuclei or GitHub). Public code makes attacks easier.What do these mean? →
- None on Exploit-DB, Metasploit or GitHub
CISA's decision points: whether it is exploited, whether attacks can be automated, and how much control an attacker gets. Assessed (SSVC 2.0.3).What do these mean? →
- Exploitation: poc
- Automatable: yes
- Technical impact: partial
Summary
The cBioPortal for Cancer Genomics provides visualization, analysis, and download of large-scale cancer genomics data sets. When running a publicly exposed proxy endpoint without authentication, cBioPortal could allow someone to perform a Server Side Request Forgery (SSRF) attack. Logged in users could do the same on private instances. A fix has been released in version 6.0.12. As a workaround, one might be able to disable `/proxy` endpoint entirely via, for example, nginx.
Timeline
- CVE published
- CISA SSVC assessment
Exploitation: poc · Automatable: yes · Technical impact: partial
- Record last updated
Affected versions
- cBioPortal cbioportal
fixed in 6.0.12